Sympatient
PrivateLast Round
Series A
Sep 29, 2022
Total Funding Raised
$9.07M
Company Overview
Sympatient is a health technology company that develops PsyOS®, a software-enabled care infrastructure designed to make psychotherapy more accessible, scalable, and efficient within regulated healthcare systems.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Telemedicine, Medical Devices, AR/VR Experiences, Patient Engagement
Business Model
B2B2C
Customer Profile
Government Contracts, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sympatient Comparables
Compare Sympatient with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HelloBetter | 87% | |
| Mindable Health | 86% | |
| MEDICE Arzneimittel Pütter | 85% | |
Sympatient Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 29, 2022 | ||||
| Seed | May 28, 2020 |
Sympatient Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Verve Ventures | Seed, Series A |
| IFB Hamburg | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors increased 77% MoM, reaching 9.4K.
- Dec 11, 2024
Grew 30% QoQ, from 54 to 70 employees.
Sympatient Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sympatient's valuation, stock price, and market status.